Solution and crystal molecular dynamics simulation study of m4-cyanovirin-N mutants complexed with di-mannose

Biophysical Journal

Volumn 97, Issue 9, 2009, Pages 2532-2540

  Vorontsov, Ivan I ^a   Miyashita, Osamu ^a  

^a University of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYANOVIRIN N; MANNOSE;

ARTICLE; BINDING SITE; COMPUTER SIMULATION; MOLECULAR DYNAMICS; PROTEIN INTERACTION; X RAY CRYSTALLOGRAPHY;

EID: 72249105167     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2009.08.011     Document Type: Article

References (50)

1. Boyd, M. R., K. R. Gustafson, J. B. McMahon, R. H. Shoemaker, B. R. O'Keefe, et al. 1997. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob. Agents Chemother. 41:1521-1530.
2. Barrientos, L. G., B. R. O'Keefe,M.Bray, A. Sanchez, A.M.Gronenborn, et al. 2003. Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus. Antiviral Res. 58:47-56.
3. Barrientos, L. G., F. Lasala, J. R. Otero, A. Sanchez, and R. Delgado. 2004. In vitro evaluation of cyanovirin-N antiviral activity, by use of lentiviral vectors pseudotyped with filovirus envelope glycoproteins. J. Infect. Dis. 189:1440-1443.
4. Helle, F., C. Wychowski, N. Vu-Dac, K. R. Gustafson, C. Voisset, et al. 2006. Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans. J. Biol. Chem. 281:25177-25183.
5. Shan, M., P. J. Klasse, K. Banerjee, A. K. Dey, S. P. Iyer, et al. 2007. HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells. PLoS Pathog. 3:e169. (Pubitemid 350291601)
6. Tsai, C. C., P. Emau, Y. Jiang, M. B. Agy, R. J. Shattock, et al. 2004. Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models. AIDS Res. Hum. Retroviruses. 20:11-18.
7. Tsai, C. C., P. Emau, Y. Jiang, B. Tian, W. R. Morton, et al. 2003. Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques. AIDS Res. Hum. Retroviruses. 19:535-541.
8. Hu, Q., N. Mahmood, and R. J. Shattock. 2007. High-mannose-specific deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N and the impact on antibody neutralization. Virology. 368:145-154. (Pubitemid 47599570)
9. Sandstrom, C., B. Hakkarainen, E. Matei, A. Glinchert, M. Lahmann, S. Oscarson, L. Kenne, and A. M. Gronenborn. 2008. Atomic mapping of the sugar interactions in one-site and two-site mutants of cyanovirin- N by NMR spectroscopy. Biochemistry. 47:3625-3635.
10. Bewley, C. A. 2001. Solution structure of a cyanovirin-N:Man α1-2Manα complex: structural basis for high-affinity carbohydrate-mediated binding to gp120. Structure. 9:931-940.
11. Barrientos, L. G., E. Matei, F. Lasala, R. Delgado, and A. M. Gronenborn. 2006. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition. Protein Eng. Des. Sel. 19:525-535.
12. Botos, I., B. R. O'Keefe, S. R. Shenoy, L. K. Cartner, D. M. Ratner, et al. 2002. Structures of the complexes of a potent anti-HIV protein cyanovirin- N and high mannose oligosaccharides. J. Biol. Chem. 277:34336-34342.
13. Botos, I., T. Mori, L. K. Cartner, M. R. Boyd, and A. Wlodawer. 2002. Domain-swapped structure of a mutant of cyanovirin-N. Biochem. Biophys. Res. Commun. 294:184-190.
14. Ziolkowska, N. E., and A. Wlodawer. 2006. Structural studies of algal lectins with anti-HIV activity. Acta Biochim. Pol. 53:617-626.
15. Fujimoto, Y. K., R. N. Terbush, V. Patsalo, and D. F. Green. 2008. Computational models explain the oligosaccharide specificity of cyanovirin- N. Protein Sci. 17:2008-2014.
16. Margulis, C. J. 2005. Computational study of the dynamics of mannose disaccharides free in solution and bound to the potent anti-HIV virucidal protein cyanovirin. J. Phys. Chem. B. 109:3639-3647.
17. Chang, L. C., and C. A. Bewley. 2002. Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants. J. Mol. Biol. 318:1-8.
18. Fromme, R., Z. Katiliene, B. Giomarelli, F. Bogani, J. McMahon, et al. 2007. A monovalent mutant of cyanovirin-N provides insight into the role of multiple interactions with gp120 for antiviral activity. Biochemistry. 46:9199-9207. (Pubitemid 47255034)
19. Barrientos, L. G., F. Lasala, R. Delgado, A. Sanchez, and A. M. Gronenborn. 2004. Flipping the switch from monomeric to dimeric CV-N has little effect on antiviral activity. Structure. 12:1799-1807.
20. Mori, T., L. G. Barrientos, Z. Han, A. M. Gronenborn, J. A. Turpin, et al. 2002. Functional homologs of cyanovirin-N amenable to mass production in prokaryotic and eukaryotic hosts. Protein Expr. Purif. 26:42-49.
21. Liu, Y., J. R. Carroll, L. A. Holt, J. McMahon, B. Giomarelli, et al. 2009. Multivalent interactions with gp120 are required for the anti- HIV activity of cyanovirin. Biopolymers. 92:194-200.
22. Fromme, R., Z. Katiliene, P. Fromme, and G. Ghirlanda. 2008. Conformational gating of dimannose binding to the antiviral protein cyanovirin revealed from the crystal structure at 1.35 A resolution. Protein Sci. 17:939-944. (Pubitemid 351629588)
23. Anselmi, M., M. Brunori, B. Vallone, and A. Di Nola. 2008. Molecular dynamics simulation of the neuroglobin crystal: comparison with the simulation in solution. Biophys. J. 95:4157-4162.
24. Neugebauer, A., C. D. Klein, and R. W. Hartmann. 2004. Protein-dynamics of the putative HCV receptor CD81 large extracellular loop. Bioorg. Med. Chem. Lett. 14:1765-1769.
25. Cerutti, D. S., I. Le Trong, R. E. Stenkamp, and T. P. Lybrand. 2008. Simulations of a protein crystal: explicit treatment of crystallization conditions links theory and experiment in the streptavidin-biotin complex. Biochemistry. 47:12065-12077.
26. Malek, K., and M. O. Coppens. 2008. Molecular simulations of solute transport in xylose isomerase crystals. J. Phys. Chem. B. 112:1549-1554.
27. Hu, Z., and J. Jiang. 2008. Molecular dynamics simulations for water and ions in protein crystals. Langmuir. 24:4215-4223. (Pubitemid 351575156)
28. Bond, P. J., J. D. Faraldo-Gomez, S. S. Deol, and M. S. Sansom. 2006. Membrane protein dynamics and detergent interactions within a crystal: a simulation study of OmpA. Proc. Natl. Acad. Sci. USA. 103:9518-9523.
29. Meinhold, L., and J. C. Smith. 2005. Fluctuations and correlations in crystalline protein dynamics: a simulation analysis of staphylococcal nuclease. Biophys J. 88:2554-2563. (Pubitemid 40976124)
30. Krieger, E., T. Darden, S. B. Nabuurs, A. Finkelstein, and G. Vriend. 2004. Making optimal use of empirical energy functions: Force-field parameterization in crystal space. Proteins. 57:678-683. (Pubitemid 39626989)
31. 2 decamer in crystal environment: comparison of atomic point-charge, extra-point, and polarizable force fields. J. Chem. Phys. 121:6998-7008.
32. Babin, V., J. Baucom, T. A. Darden, and C. Sagui. 2006. Molecular dynamics simulations of DNA with polarizable force fields: convergence of an ideal B-DNA structure to the crystallographic structure. J. Phys. Chem. B. 110:11571-11581.
33. Shao, J., S. W. Tanner, N. Thompson, and T. E. Cheatham. 2007. Clustering molecular dynamics trajectories: 1. characterizing the performance of different clustering algorithms. J. Chem. Theory Comput. 3:2312-2334.
34. Rao, F., and A. Caflisch. 2004. The protein folding network. J. Mol. Biol. 342:299-306.
35. Case, D. A., T. E. Cheatham, 3rd, T. Darden, H. Gohlke, R. Luo, et al. 2005. The AMBER biomolecular simulation programs. J. Comput. Chem. 26:1668-1688.
36. Case, D. A., T. A. Darden, T. E. Cheatham, 3rd, C. L. Simmerling, J.Wang, et al. 2008.AMBER10. University of California, San Francisco.
37. Case, D.A., editor. 2008. AmberTools Users' Manual.
38. Duan, Y., C. Wu, S. Chowdhury, M. C. Lee, G. Xiong, et al. 2003. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem. 24:1999-2012.
39. Kirschner, K. N., A. B. Yongye, S. M. Tschampel, J. Gonzalez-Outeirino, C. R. Daniels, et al. 2008. GLYCAM06: a generalizable biomolecular force field. Carbohydrates. J. Comput. Chem. 29:622-655.
40. Ponder, J. W., and D. A. Case. 2003. Force fields for protein simulations. Adv. Protein Chem. 66:27-85.
41. DeMarco, M. L., and R. J. Woods. 2004. 2008. Structural glycobiology: a game of snakes and ladders. Glycobiology. 18:426-440.
42. Cerutti, D. S., R. Duke, P. L. Freddolino, H. Fan, and T. P. Lybrand. 2008. Vulnerability in popular molecular dynamics packages concerning Langevin and Andersen dynamics. J. Chem. Theory Comput. 4:1669-1680.
43. Humphrey, W., A. Dalke, and K. Schulten. 1996. VMD: visual molecular dynamics. J. Mol. Graph. 14:33-38.
44. DeLano, W. L. 2008. The PyMOL Molecular Graphics System. DeLano Scientific, Palo Alto, CA, USA.
45. Wallace, A. C., R. A. Laskowski, and J. M. Thornton. 1995. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8:127-134.
46. Shannon, P., A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang, et al. 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498-2504. (Pubitemid 37428274)
47. Lovell, S. C., J. M. Word, J. S. Richardson, and D. C. Richardson. 2000. The penultimate rotamer library. Proteins. 40:389-408.
48. Vorontsov, I. I., and P. Coppens. 2005. On the refinement of time-resolved diffraction data: comparison of the random-distribution and cluster-formation models and analysis of the light-induced increase in the atomic displacement parameters. J. Synchrotron. Radiat. 12:488-493.
49. Percudani, R., B. Montanini, and S. Ottonello. 2005. The anti-HIV cyanovirin-N domain is evolutionarily conserved and occurs as a protein module in eukaryotes. Proteins. 60:670-678. (Pubitemid 41266424)
50. Koharudin, L. M., A. R. Viscomi, J. G. Jee, S. Ottonello, and A. M. Gronenborn. 2008. The evolutionarily conserved family of cyanovirin- N homologs: structures and carbohydrate specificity. Structure. 16:570-584.